Market Overview

The Global Cancer Vaccine Market was valued at USD 8,918.5 million in 2023 and is expected to reach USD 21,458.8 million by 2031 while growing at a CAGR of 11.6% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cancer vaccine market growth. Vaccines are medicinal interventions that assist the body in combating diseases by training the immune system to detect and eliminate harmful pathogens and cells. Throughout life, individuals receive various vaccines to safeguard against prevalent illnesses. Additionally, there are vaccines designed to prevent and treat cancer, offering protection against certain types of cancer or aiding in cancer treatment.

The growth of the market is propelled by factors such as increasing cancer incidence, advancements in immunotherapy, and a focus on preventive medicine. However, challenges like the complexity of cancer biology and high development costs impede market expansion.

Furthermore, the global cancer vaccine industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Cancer Vaccine Market is segmented among Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, based on Type. In 2023, Preventive Cancer Vaccines accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Indication Type Analysis

The Global Cancer Vaccine Market is segmented among Prostate Cancer, Bladder Cancer, Melanoma, Cervical Cancer, and Others, based on Indication Type. In 2023, Cervical Cancer accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Cancer Vaccine Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Merck & Co., Inc., GSK plc, Dendreon Pharmaceuticals LLC., Dynavax Technologies., Ferring B.V., Amgen, Inc., Moderna, Inc., Sanofi, AstraZeneca, and Bristol-Myers Squibb Company.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Cancer Vaccine Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Cancer Vaccine Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Cancer Vaccine Market Segmentation, By Type

• Global Cancer Vaccine Market Share Analysis, By Type

• Global Cancer Vaccine Market Growth Analysis, By Type

• Global Cancer Vaccine Market Trends, By Type

o Preventive Cancer Vaccines

o Therapeutic Cancer Vaccines

6. Global Cancer Vaccine Market Segmentation, By Indication Type

• Global Cancer Vaccine Market Share Analysis, By Indication Type

• Global Cancer Vaccine Market Growth Analysis, By Indication Type

• Global Cancer Vaccine Market Trends, By Indication Type

o Prostate Cancer

o Bladder Cancer

o Melanoma

o Cervical Cancer

o Others

7. Global Cancer Vaccine Market Segmentation, By Technology Type

• Global Cancer Vaccine Market Share Analysis, By Technology Type

• Global Cancer Vaccine Market Growth Analysis, By Technology Type

• Global Cancer Vaccine Market Trends, By Technology Type

o Recombinant Cancer Vaccines

o Whole-cell Cancer Vaccines

o Viral Vector and DNA Cancer Vaccines

o Other Technologies

8. Global Cancer Vaccine Market Segmentation, By Region

• Global Cancer Vaccine Market Share Analysis, By Region

• Global Cancer Vaccine Market Growth Analysis, By Region

• Global Cancer Vaccine Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Merck & Co., Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• GSK plc

• Dendreon Pharmaceuticals LLC.

• Dynavax Technologies.

• Ferring B.V.

• Amgen, Inc.

• Moderna, Inc.

• Sanofi

• AstraZeneca

• Bristol-Myers Squibb Company

*Similar analysis will be provided for each company listed above.